ArticleFrontiers in oncology2025

Successful treatment with carfilzomib and dexamethasone for relapsed/refractory POEMS syndrome: a case report and review of literature.

Shuang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.